Neurofibromatosis Type 1
ICD-10: LD2D.10MeSH: D009456ORPHA: ORPHA:6361 Treatment Available
Overview
A rare autosomal-dominant disorder caused by NF1 gene mutations, characterized by cafe-au-lait macules, cutaneous and plexiform neurofibromas, Lisch nodules, and increased tumor risk.
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| mirdametinib Orphan | — | FDA Approved (2025) | 1 | — |
Classification & Codes
ICD-10 Code
LD2D.10MeSH Code
D009456Orphanet Code
ORPHA:ORPHA:636Neurofibromatosis Type 1
| ICD-10 | LD2D.10 |
| MeSH | D009456 |
| Orphanet | ORPHA:ORPHA:636 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated7/24/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO